Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Geoff Meacham is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/13/2025 | MRNA | Buy Now | Moderna | $33.70 | 18.69% | Geoff Meacham63% | → $40 | Initiates | → Neutral | Get Alert |
| 03/13/2025 | KYMR | Buy Now | Kymera Therapeutics | $34.03 | 52.81% | Geoff Meacham63% | → $52 | Initiates | → Buy | Get Alert |
| 03/13/2025 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $22.61 | 76.91% | Geoff Meacham63% | → $40 | Initiates | → Buy | Get Alert |
| 03/13/2025 | BNTX | Buy Now | BioNTech | $98.96 | 46.52% | Geoff Meacham63% | → $145 | Initiates | → Buy | Get Alert |
| 03/13/2025 | RNA | Buy Now | Avidity Biosciences | $30.48 | 129.66% | Geoff Meacham63% | → $70 | Initiates | → Buy | Get Alert |
| 03/13/2025 | APGE | Buy Now | Apogee Therapeutics | $39.01 | 143.53% | Geoff Meacham63% | → $95 | Initiates | → Buy | Get Alert |
| 03/13/2025 | ETNB | Buy Now | 89bio | $8.55 | 192.4% | Geoff Meacham63% | → $25 | Initiates | → Buy | Get Alert |
| 03/10/2025 | RNA | Buy Now | Avidity Biosciences | $30.48 | 57.48% | Geoff Meacham63% | $51 → $48 | Maintains | Buy | Get Alert |
| 02/20/2025 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 43.96% | Geoff Meacham63% | $99 → $103 | Maintains | Buy | Get Alert |
| 02/13/2025 | BIIB | Buy Now | Biogen | $143.09 | 1.33% | Geoff Meacham63% | $160 → $145 | Maintains | Neutral | Get Alert |
| 02/03/2025 | ABBV | Buy Now | AbbVie | $214.59 | 0.19% | Geoff Meacham63% | $205 → $215 | Maintains | Buy | Get Alert |
| 01/28/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 12.79% | Geoff Meacham63% | $795 → $750 | Maintains | Neutral | Get Alert |
| 01/28/2025 | BIIB | Buy Now | Biogen | $143.09 | 11.82% | Geoff Meacham63% | $190 → $160 | Maintains | Neutral | Get Alert |
| 01/28/2025 | AMGN | Buy Now | Amgen | $319.93 | -7.79% | Geoff Meacham63% | $310 → $295 | Maintains | Neutral | Get Alert |
| 01/28/2025 | ABBV | Buy Now | AbbVie | $214.59 | -4.47% | Geoff Meacham63% | $215 → $205 | Maintains | Buy | Get Alert |
| 01/14/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 19.56% | Geoff Meacham63% | $895 → $795 | Maintains | Neutral | Get Alert |
| 01/07/2025 | CRSP | Buy Now | CRISPR Therapeutics | $40.97 | 107.47% | Geoff Meacham63% | $98 → $85 | Maintains | Buy | Get Alert |
| 01/07/2025 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | -89.36% | Geoff Meacham63% | $112 → $4 | Downgrade | Buy → Underperform | Get Alert |
| 01/06/2025 | NMRA | Buy Now | Neumora Therapeutics | $1.18 | 494.08% | Geoff Meacham63% | $22 → $7 | Maintains | Buy | Get Alert |
| 11/25/2024 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 42.86% | Geoff Meacham63% | $42 → $45 | Maintains | Buy | Get Alert |
| 11/14/2024 | GILD | Buy Now | Gilead Sciences | $106.96 | 16.87% | Geoff Meacham63% | → $125 | Initiates | → Buy | Get Alert |
| 11/14/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 34.59% | Geoff Meacham63% | → $895 | Initiates | → Neutral | Get Alert |
| 11/14/2024 | BIIB | Buy Now | Biogen | $143.09 | 32.78% | Geoff Meacham63% | → $190 | Initiates | → Neutral | Get Alert |
| 11/14/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | 12.25% | Geoff Meacham63% | → $575 | Initiates | → Buy | Get Alert |
| 11/14/2024 | AMGN | Buy Now | Amgen | $319.93 | 4.71% | Geoff Meacham63% | → $335 | Initiates | → Neutral | Get Alert |
| 11/12/2024 | ABBV | Buy Now | AbbVie | $214.59 | 0.19% | Geoff Meacham63% | $226 → $215 | Maintains | Buy | Get Alert |
| 10/31/2024 | ABBV | Buy Now | AbbVie | $214.59 | 5.31% | Geoff Meacham63% | $215 → $226 | Maintains | Buy | Get Alert |
| 10/31/2024 | LLY | Buy Now | Eli Lilly | $821.00 | 33.98% | Geoff Meacham63% | $1150 → $1100 | Maintains | Buy | Get Alert |
| 10/30/2024 | LYEL | Buy Now | Lyell Immunopharma | $0.57 | 76.8% | Geoff Meacham63% | $6 → $1 | Downgrade | Buy → Underperform | Get Alert |
| 10/18/2024 | ABBV | Buy Now | AbbVie | $214.59 | -9.13% | Geoff Meacham63% | $185 → $195 | Maintains | Neutral | Get Alert |
| 10/18/2024 | TYRA | Buy Now | Tyra Biosciences | $10.88 | 184.93% | Geoff Meacham63% | $22 → $31 | Upgrade | Neutral → Buy | Get Alert |
| 09/17/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 60.73% | Geoff Meacham63% | $130 → $115 | Maintains | Buy | Get Alert |
| 09/13/2024 | MRNA | Buy Now | Moderna | $33.70 | 226.41% | Geoff Meacham63% | $130 → $110 | Maintains | Neutral | Get Alert |
| 09/11/2024 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 33.33% | Geoff Meacham63% | $42 → $42 | Maintains | Buy | Get Alert |
| 08/19/2024 | TSBX | Buy Now | Turnstone Biologics | $0.37 | 2610.76% | Geoff Meacham63% | $12 → $10 | Maintains | Buy | Get Alert |
| 08/09/2024 | LLY | Buy Now | Eli Lilly | $821.00 | 37.03% | Geoff Meacham63% | $1000 → $1125 | Maintains | Buy | Get Alert |
| 08/07/2024 | AMGN | Buy Now | Amgen | $319.93 | 3.15% | Geoff Meacham63% | $325 → $330 | Maintains | Neutral | Get Alert |
| 07/31/2024 | MRK | Buy Now | Merck & Co | $94.90 | 52.79% | Geoff Meacham63% | $150 → $145 | Maintains | Buy | Get Alert |
| 06/27/2024 | LYEL | Buy Now | Lyell Immunopharma | $0.57 | 960.82% | Geoff Meacham63% | $9 → $6 | Maintains | Buy | Get Alert |
| 06/25/2024 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 33.33% | Geoff Meacham63% | $50 → $42 | Maintains | Buy | Get Alert |
| 06/24/2024 | LLY | Buy Now | Eli Lilly and Co | $821.00 | 21.8% | Geoff Meacham63% | $1000 → $1000 | Maintains | Buy | Get Alert |
| 06/13/2024 | RNA | Buy Now | Avidity Biosciences | $30.48 | 47.64% | Geoff Meacham63% | $40 → $45 | Maintains | Buy | Get Alert |
| 05/10/2024 | APGE | Buy Now | Apogee Therapeutics | $39.01 | 105.08% | Geoff Meacham63% | → $80 | Initiates | → Buy | Get Alert |
| 05/03/2024 | RNA | Buy Now | Avidity Biosciences | $30.48 | 31.23% | Geoff Meacham63% | → $40 | Initiates | → Buy | Get Alert |
| 04/17/2024 | JNJ | Buy Now | Johnson & Johnson | $164.25 | 3.5% | Geoff Meacham63% | $180 → $170 | Maintains | Neutral | Get Alert |
| 04/12/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | 8.28% | Geoff Meacham63% | $710 → $720 | Maintains | Underperform | Get Alert |
| 04/12/2024 | RPRX | Buy Now | Royalty Pharma | $33.66 | 12.89% | Geoff Meacham63% | $40 → $38 | Maintains | Buy | Get Alert |
| 04/12/2024 | BIIB | Buy Now | Biogen | $143.09 | 81.7% | Geoff Meacham63% | $280 → $260 | Maintains | Neutral | Get Alert |
| 03/13/2024 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | 197.87% | Geoff Meacham63% | $128 → $112 | Maintains | Buy | Get Alert |
| 03/13/2024 | JANX | Buy Now | Janux Therapeutics | $30.93 | 55.19% | Geoff Meacham63% | $24 → $48 | Maintains | Buy | Get Alert |
| 03/01/2024 | LLY | Buy Now | Eli Lilly and Co | $821.00 | 21.8% | Geoff Meacham63% | $800 → $1000 | Maintains | Buy | Get Alert |
| 01/03/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.03 | -11.84% | Geoff Meacham63% | $45 → $30 | Downgrade | Buy → Neutral | Get Alert |
| 01/03/2024 | LIAN | Buy Now | LianBio | — | — | Geoff Meacham63% | $5 → $3 | Downgrade | Buy → Underperform | Get Alert |
| 01/03/2024 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | — | Geoff Meacham63% | $68 → $60 | Downgrade | Buy → Neutral | Get Alert |
| 12/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 13.33% | Geoff Meacham63% | $72 → $68 | Maintains | Buy | Get Alert |
| 12/15/2023 | IGMS | Buy Now | IGM Biosciences | $1.21 | 563.9% | Geoff Meacham63% | → $8 | Downgrade | Buy → Neutral | Get Alert |
| 10/11/2023 | AMGN | Buy Now | Amgen | $319.93 | -9.35% | Geoff Meacham63% | → $290 | Reinstates | → Neutral | Get Alert |
| 10/10/2023 | NMRA | Buy Now | Neumora Therapeutics | $1.18 | 1427.62% | Geoff Meacham63% | → $18 | Initiates | → Buy | Get Alert |
| 09/08/2023 | VIR | Buy Now | Vir Biotechnology | $6.93 | 102.02% | Geoff Meacham63% | $23 → $14 | Downgrade | Buy → Neutral | Get Alert |
| 09/08/2023 | GILD | Buy Now | Gilead Sciences | $106.96 | -11.18% | Geoff Meacham63% | $88 → $95 | Upgrade | Neutral → Buy | Get Alert |
| 08/21/2023 | CVAC | Buy Now | CureVac | $3.03 | 164.03% | Geoff Meacham63% | $10 → $8 | Maintains | Underperform | Get Alert |
| 08/21/2023 | RANI | Buy Now | Rani Therapeutics Hldgs | $1.51 | 1025.83% | Geoff Meacham63% | $19 → $17 | Maintains | Buy | Get Alert |
| 08/15/2023 | TSBX | Buy Now | Turnstone Biologics | $0.37 | 4779.37% | Geoff Meacham63% | → $18 | Initiates | → Buy | Get Alert |
| 08/04/2023 | MRNA | Buy Now | Moderna | $33.70 | 345.1% | Geoff Meacham63% | $175 → $150 | Maintains | Neutral | Get Alert |
| 07/28/2023 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 33.33% | Geoff Meacham63% | $85 → $80 | Maintains | Buy | Get Alert |
| 07/21/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $71.55 | 158.56% | Geoff Meacham63% | $200 → $185 | Maintains | Buy | Get Alert |
| 07/20/2023 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.21 | 1057.02% | Geoff Meacham63% | → $14 | Reinstates | → Buy | Get Alert |
| 05/23/2023 | ICPT | Buy Now | Intercept Pharma | — | — | Geoff Meacham63% | $17 → $14 | Maintains | Underperform | Get Alert |
| 05/04/2023 | BIIB | Buy Now | Biogen | $143.09 | 123.64% | Geoff Meacham63% | $300 → $320 | Maintains | Neutral | Get Alert |
| 04/21/2023 | PFE | Buy Now | Pfizer | $26.30 | 71.09% | Geoff Meacham63% | $50 → $45 | Maintains | Neutral | Get Alert |
| 04/21/2023 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 41.67% | Geoff Meacham63% | $82 → $85 | Maintains | Buy | Get Alert |
| 04/21/2023 | BIIB | Buy Now | Biogen | $143.09 | 109.66% | Geoff Meacham63% | $295 → $300 | Maintains | Neutral | Get Alert |
| 02/23/2023 | GRPH | Buy Now | Graphite Bio | — | — | Geoff Meacham63% | $21 → $14 | Downgrade | Neutral → Underperform | Get Alert |
| 01/18/2023 | GRPH | Buy Now | Graphite Bio | — | — | Geoff Meacham63% | $49 → $21 | Downgrade | Buy → Neutral | Get Alert |
| 01/05/2023 | AMLX | Buy Now | Amylyx Pharma | $3.64 | 1273.63% | Geoff Meacham63% | → $50 | Initiates | → Buy | Get Alert |
| 01/04/2023 | MRK | Buy Now | Merck & Co | $94.90 | 36.99% | Geoff Meacham63% | $110 → $130 | Upgrade | Neutral → Buy | Get Alert |
| 01/04/2023 | PFE | Buy Now | Pfizer | $26.30 | 128.13% | Geoff Meacham63% | → $60 | Downgrade | Buy → Neutral | Get Alert |
| 12/14/2022 | ABBV | Buy Now | AbbVie | $214.59 | -23.11% | Geoff Meacham63% | $162 → $165 | Maintains | Neutral | Get Alert |
| 12/13/2022 | GILD | Buy Now | Gilead Sciences | $106.96 | -20.53% | Geoff Meacham63% | → $85 | Reinstates | → Neutral | Get Alert |
| 12/05/2022 | ABBV | Buy Now | AbbVie | $214.59 | -24.51% | Geoff Meacham63% | $160 → $162 | Maintains | Neutral | Get Alert |
| 11/01/2022 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | -5.66% | Geoff Meacham63% | → $24 | Downgrade | Neutral → Underperform | Get Alert |
| 10/03/2022 | ICPT | Buy Now | Intercept Pharma | — | — | Geoff Meacham63% | $16 → $14 | Maintains | Underperform | Get Alert |
| 08/29/2022 | IGMS | Buy Now | IGM Biosciences | $1.21 | 2721.58% | Geoff Meacham63% | → $34 | Initiates | → Buy | Get Alert |
| 07/07/2022 | LLY | Buy Now | Eli Lilly | $821.00 | -56.76% | Geoff Meacham63% | $333 → $355 | Maintains | Overweight | Get Alert |
| 06/21/2022 | ABBV | Buy Now | AbbVie | $214.59 | -27.3% | Geoff Meacham63% | → $156 | Reiterates | → Neutral | Get Alert |
| 06/08/2022 | OMER | Buy Now | Omeros | $8.92 | -55.16% | Geoff Meacham63% | $12 → $4 | Downgrade | Buy → Neutral | Get Alert |
| 04/22/2022 | ABBV | Buy Now | AbbVie | $214.59 | -27.3% | Geoff Meacham63% | $152 → $156 | Maintains | Neutral | Get Alert |
| 03/28/2022 | BIIB | Buy Now | Biogen | $143.09 | 57.24% | Geoff Meacham63% | $230 → $225 | Maintains | Neutral | Get Alert |
| 03/17/2022 | ABBV | Buy Now | AbbVie | $214.59 | -29.17% | Geoff Meacham63% | $145 → $152 | Maintains | Neutral | Get Alert |
| 02/03/2022 | ABBV | Buy Now | AbbVie | $214.59 | -35.69% | Geoff Meacham63% | $135 → $138 | Maintains | Neutral | Get Alert |
| 01/21/2022 | CVAC | Buy Now | CureVac | $3.03 | 560.07% | Geoff Meacham63% | $55 → $20 | Downgrade | Neutral → Underperform | Get Alert |
| 01/21/2022 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.21 | 1057.02% | Geoff Meacham63% | $16 → $14 | Upgrade | Neutral → Buy | Get Alert |
| 01/21/2022 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | 371.72% | Geoff Meacham63% | $96 → $120 | Upgrade | Underperform → Neutral | Get Alert |
| 01/21/2022 | MRNA | Buy Now | Moderna | $33.70 | 434.12% | Geoff Meacham63% | $135 → $180 | Upgrade | Underperform → Neutral | Get Alert |
| 01/05/2022 | AMGN | Buy Now | Amgen | $319.93 | -20.29% | Geoff Meacham63% | $285 → $255 | Downgrade | Buy → Neutral | Get Alert |
| 01/05/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -13.53% | Geoff Meacham63% | $675 → $575 | Downgrade | Neutral → Underperform | Get Alert |
| 01/05/2022 | PFE | Buy Now | Pfizer | $26.30 | 166.15% | Geoff Meacham63% | $59 → $70 | Upgrade | Neutral → Buy | Get Alert |
| 12/29/2021 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $22.61 | 50.38% | Geoff Meacham63% | $37 → $34 | Maintains | Buy | Get Alert |
| 12/23/2021 | BIIB | Buy Now | Biogen | $143.09 | 92.19% | Geoff Meacham63% | $295 → $275 | Maintains | Neutral | Get Alert |
| 12/06/2021 | VAXX | Buy Now | Vaxxinity | — | — | Geoff Meacham63% | → $21 | Initiates | → Buy | Get Alert |
| 10/11/2021 | TYRA | Buy Now | Tyra Biosciences | $10.88 | 102.21% | Geoff Meacham63% | → $22 | Initiates | → Buy | Get Alert |
| 10/06/2021 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | Geoff Meacham63% | → $7 | Upgrade | Neutral → Buy | Get Alert |
| 09/10/2021 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | 277.38% | Geoff Meacham63% | $108 → $96 | Downgrade | Neutral → Underperform | Get Alert |
| 09/10/2021 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 138.1% | Geoff Meacham63% | → $75 | Upgrade | Neutral → Buy | Get Alert |
| 09/10/2021 | KYMR | Buy Now | Kymera Therapeutics | $34.03 | 135.09% | Geoff Meacham63% | $65 → $80 | Upgrade | Neutral → Buy | Get Alert |
| 08/10/2021 | ERAS | Buy Now | Erasca | $1.40 | 1900% | Geoff Meacham63% | → $28 | Initiates | → Buy | Get Alert |
| 08/02/2021 | ABBV | Buy Now | AbbVie | $214.59 | -44.55% | Geoff Meacham63% | $115 → $119 | Maintains | Neutral | Get Alert |
| 07/26/2021 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.21 | 1552.89% | Geoff Meacham63% | → $20 | Initiates | → Neutral | Get Alert |
| 07/20/2021 | GRPH | Buy Now | Graphite Bio | — | — | Geoff Meacham63% | → $245 | Initiates | → Buy | Get Alert |
| 07/13/2021 | IPSC | Buy Now | Century Therapeutics | $0.61 | 5505.94% | Geoff Meacham63% | → $34 | Initiates | → Buy | Get Alert |
| 07/12/2021 | LYEL | Buy Now | Lyell Immunopharma | $0.57 | 4320.08% | Geoff Meacham63% | → $25 | Initiates | → Buy | Get Alert |
| 07/06/2021 | JANX | Buy Now | Janux Therapeutics | $30.93 | 13.16% | Geoff Meacham63% | → $35 | Initiates | → Buy | Get Alert |
| 06/17/2021 | CVAC | Buy Now | CureVac | $3.03 | 1550.17% | Geoff Meacham63% | → $50 | Downgrade | Buy → Neutral | Get Alert |
| 05/19/2021 | ABBV | Buy Now | AbbVie | $214.59 | -47.34% | Geoff Meacham63% | $110 → $113 | Maintains | Neutral | Get Alert |
| 05/07/2021 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.54 | 1133.48% | Geoff Meacham63% | $56 → $56 | Upgrade | Neutral → Buy | Get Alert |
| 03/23/2021 | INO | Buy Now | Inovio Pharmaceuticals | $2.12 | 513.24% | Geoff Meacham63% | → $156 | Initiates | → Neutral | Get Alert |
| 02/01/2021 | MRNA | Buy Now | Moderna | $33.70 | — | Geoff Meacham63% | — | Downgrade | Neutral → Underperform | Get Alert |
| 01/22/2021 | MRNA | Buy Now | Moderna | $33.70 | 315.43% | Geoff Meacham63% | $130 → $140 | Maintains | Neutral | Get Alert |
| 01/15/2021 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.54 | 1133.48% | Geoff Meacham63% | → $56 | Downgrade | Buy → Neutral | Get Alert |
| 01/15/2021 | ICPT | Buy Now | Intercept Pharma | — | — | Geoff Meacham63% | — | Downgrade | Neutral → Underperform | Get Alert |
| 01/15/2021 | ESPR | Buy Now | Esperion Therapeutics | $1.58 | 2115.19% | Geoff Meacham63% | → $35 | Downgrade | Buy → Neutral | Get Alert |
| 01/15/2021 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | — | Upgrade | Neutral → Buy | Get Alert |
| 01/05/2021 | ICPT | Buy Now | Intercept Pharma | — | — | Geoff Meacham63% | $55 → $40 | Maintains | Neutral | Get Alert |
| 12/11/2020 | ABBV | Buy Now | AbbVie | $214.59 | -48.74% | Geoff Meacham63% | $97 → $110 | Maintains | Neutral | Get Alert |
| 11/23/2020 | GLTO | Buy Now | Galecto | $3.97 | 428.5% | Geoff Meacham63% | → $525 | Initiates | → Buy | Get Alert |
| 11/09/2020 | BIIB | Buy Now | Biogen | $143.09 | 67.73% | Geoff Meacham63% | → $240 | Downgrade | Neutral → Underperform | Get Alert |
| 11/05/2020 | BIIB | Buy Now | Biogen | $143.09 | 151.59% | Geoff Meacham63% | $230 → $360 | Upgrade | Underperform → Neutral | Get Alert |
| 10/29/2020 | AMGN | Buy Now | Amgen | $319.93 | -17.17% | Geoff Meacham63% | $275 → $265 | Maintains | Buy | Get Alert |
| 10/20/2020 | PMVP | Buy Now | PMV Pharma | $1.27 | 3207.09% | Geoff Meacham63% | → $42 | Initiates | → Buy | Get Alert |
| 10/20/2020 | OMER | Buy Now | Omeros | $8.92 | 135.43% | Geoff Meacham63% | → $21 | Initiates | → Buy | Get Alert |
| 10/15/2020 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $180 → $215 | Maintains | Neutral | Get Alert |
| 10/15/2020 | ESPR | Buy Now | Esperion Therapeutics | $1.58 | 3191.14% | Geoff Meacham63% | $55 → $52 | Maintains | Buy | Get Alert |
| 10/15/2020 | BIIB | Buy Now | Biogen | $143.09 | 64.23% | Geoff Meacham63% | $255 → $235 | Maintains | Underperform | Get Alert |
| 10/07/2020 | YMAB | Buy Now | Y-mAbs Therapeutics | $4.54 | 913.22% | Geoff Meacham63% | $48 → $46 | Upgrade | Neutral → Buy | Get Alert |
| 10/05/2020 | VIR | Buy Now | Vir Biotechnology | $6.93 | 693.65% | Geoff Meacham63% | → $55 | Initiates | → Buy | Get Alert |
| 10/05/2020 | CRSP | Buy Now | CRISPR Therapeutics | $40.97 | 168.49% | Geoff Meacham63% | → $110 | Initiates | → Buy | Get Alert |
| 09/15/2020 | MGTX | Buy Now | MeiraGTx Hldgs | $7.34 | 172.38% | Geoff Meacham63% | → $20 | Reinstates | → Buy | Get Alert |
| 09/15/2020 | KYMR | Buy Now | Kymera Therapeutics | $34.03 | 2.85% | Geoff Meacham63% | → $35 | Initiates | → Neutral | Get Alert |
| 09/08/2020 | CVAC | Buy Now | CureVac | $3.03 | 2210.23% | Geoff Meacham63% | → $70 | Initiates | → Buy | Get Alert |
| 09/08/2020 | SGMO | Buy Now | Sangamo Therapeutics | $0.85 | 2252.66% | Geoff Meacham63% | → $20 | Reinstates | → Buy | Get Alert |
| 09/01/2020 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | Geoff Meacham63% | → $19 | Initiates | → Neutral | Get Alert |
| 08/17/2020 | ESPR | Buy Now | Esperion Therapeutics | $1.58 | 3381.01% | Geoff Meacham63% | $60 → $55 | Maintains | Buy | Get Alert |
| 08/04/2020 | PSTX | Buy Now | Poseida Therapeutics | — | — | Geoff Meacham63% | → $20 | Initiates | → Buy | Get Alert |
| 07/13/2020 | RPRX | Buy Now | Royalty Pharma | $33.66 | 63.4% | Geoff Meacham63% | → $55 | Initiates | → Buy | Get Alert |
| 07/13/2020 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | 2580.85% | Geoff Meacham63% | $848 → $1008 | Reiterates | → Buy | Get Alert |
| 06/25/2020 | PBYI | Buy Now | Puma Biotechnology | $3.34 | 169.46% | Geoff Meacham63% | → $9 | Reinstates | → Underperform | Get Alert |
| 06/25/2020 | BBIO | Buy Now | BridgeBio Pharma | $31.50 | 20.63% | Geoff Meacham63% | → $38 | Initiates | → Neutral | Get Alert |
| 06/25/2020 | RGNX | Buy Now | Regenxbio | $7.86 | 663.36% | Geoff Meacham63% | → $60 | Reinstates | → Buy | Get Alert |
| 06/25/2020 | GNFT | Buy Now | Genfit | $3.62 | 93.37% | Geoff Meacham63% | → $7 | Initiates | → Underperform | Get Alert |
| 05/19/2020 | MRNA | Buy Now | Moderna | $33.70 | 181.9% | Geoff Meacham63% | $70 → $95 | Maintains | Neutral | Get Alert |
| 05/01/2020 | AMGN | Buy Now | Amgen | $319.93 | -17.17% | Geoff Meacham63% | $250 → $265 | Reiterates | → Buy | Get Alert |
| 04/01/2020 | KNSA | Buy Now | Kiniksa Pharmaceuticals | $22.61 | 10.57% | Geoff Meacham63% | → $25 | Initiates | → Buy | Get Alert |
| 04/01/2020 | ESPR | Buy Now | Esperion Therapeutics | $1.58 | 3064.56% | Geoff Meacham63% | → $50 | Initiates | → Buy | Get Alert |
| 04/01/2020 | EIDX | Buy Now | Eidos Therapeutics | — | — | Geoff Meacham63% | → $51 | Initiates | → Neutral | Get Alert |
| 04/01/2020 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | 1814.89% | Geoff Meacham63% | → $720 | Initiates | → Buy | Get Alert |
| 03/23/2020 | IIVI | Buy Now | II-VI | — | — | Geoff Meacham63% | → $31 | Initiates | → Overweight | Get Alert |
| 03/05/2020 | MRNA | Buy Now | Moderna | $33.70 | — | Geoff Meacham63% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/05/2020 | AMGN | Buy Now | Amgen | $319.93 | -21.86% | Geoff Meacham63% | $245 → $250 | Upgrade | Neutral → Buy | Get Alert |
| 03/05/2020 | ICPT | Buy Now | Intercept Pharma | — | — | Geoff Meacham63% | → $111 | Initiates | → Neutral | Get Alert |
| 03/05/2020 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Geoff Meacham63% | $130 → $110 | Downgrade | Buy → Neutral | Get Alert |
| 02/25/2020 | RTRX | Buy Now | Retrophin | — | — | Geoff Meacham63% | → $19 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/18/2020 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | → $124 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/03/2019 | MRNA | Buy Now | Moderna | $33.70 | -13.95% | Geoff Meacham63% | → $29 | Reinstates | → Buy | Get Alert |
| 10/17/2019 | AMGN | Buy Now | Amgen | $319.93 | -32.8% | Geoff Meacham63% | → $215 | Reinstates | → Neutral | Get Alert |
| 10/17/2019 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -51.12% | Geoff Meacham63% | → $325 | Reinstates | → Neutral | Get Alert |
| 08/23/2019 | RTRX | Buy Now | Retrophin | — | — | Geoff Meacham63% | $36 → $20 | Maintains | Overweight | Get Alert |
| 08/05/2019 | ZYME | Buy Now | Zymeworks | $12.34 | 86.39% | Geoff Meacham63% | $15 → $23 | Maintains | Equal-Weight | Get Alert |
| 05/09/2019 | BIIB | Buy Now | Biogen | $143.09 | 71.22% | Geoff Meacham63% | $250 → $245 | Maintains | Equal-Weight | Get Alert |
| 05/03/2019 | INCY | Buy Now | Incyte | $60.00 | 36.67% | Geoff Meacham63% | $90 → $82 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/03/2019 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/03/2019 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | -8.33% | Geoff Meacham63% | $53 → $55 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/22/2019 | RTRX | Buy Now | Retrophin | — | — | Geoff Meacham63% | → $36 | Initiates | → Overweight | Get Alert |
| 03/01/2019 | UTHR | Buy Now | United Therapeutics | $314.12 | -69.76% | Geoff Meacham63% | $100 → $95 | Maintains | Underweight | Get Alert |
| 02/13/2019 | MYOV | Buy Now | Myovant Sciences | — | — | Geoff Meacham63% | $22 → $25 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 01/02/2019 | MRNA | Buy Now | Moderna | $33.70 | -40.65% | Geoff Meacham63% | → $20 | Initiates | → Buy | Get Alert |
| 12/20/2018 | DBVT | Buy Now | DBV Technologies | $5.01 | 59.68% | Geoff Meacham63% | $300 → $80 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/06/2018 | PTCT | Buy Now | PTC Therapeutics | $56.00 | -28.57% | Geoff Meacham63% | $43 → $40 | Maintains | Equal-Weight | Get Alert |
| 10/26/2018 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $95 → $90 | Maintains | Overweight | Get Alert |
| 10/23/2018 | GRTS | Buy Now | Gritstone Bio | — | — | Geoff Meacham63% | → $25 | Initiates | → Overweight | Get Alert |
| 10/12/2018 | MRK | Buy Now | Merck & Co | $94.90 | -17.81% | Geoff Meacham63% | $75 → $78 | Maintains | Overweight | Get Alert |
| 10/12/2018 | LLY | Buy Now | Eli Lilly | $821.00 | -85.38% | Geoff Meacham63% | $112 → $120 | Maintains | Overweight | Get Alert |
| 10/12/2018 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | -3.33% | Geoff Meacham63% | $55 → $58 | Maintains | Equal-Weight | Get Alert |
| 10/03/2018 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $80 → $95 | Maintains | Overweight | Get Alert |
| 09/18/2018 | LLY | Buy Now | Eli Lilly | $821.00 | -86.36% | Geoff Meacham63% | $107 → $112 | Maintains | Overweight | Get Alert |
| 09/07/2018 | MRK | Buy Now | Merck & Co | $94.90 | -20.97% | Geoff Meacham63% | $70 → $75 | Maintains | Overweight | Get Alert |
| 09/07/2018 | LLY | Buy Now | Eli Lilly | $821.00 | -86.97% | Geoff Meacham63% | $98 → $107 | Maintains | Overweight | Get Alert |
| 08/23/2018 | PFE | Buy Now | Pfizer | $26.30 | 52.08% | Geoff Meacham63% | $38 → $40 | Maintains | Equal-Weight | Get Alert |
| 08/08/2018 | PTCT | Buy Now | PTC Therapeutics | $56.00 | -23.21% | Geoff Meacham63% | $40 → $43 | Maintains | Equal-Weight | Get Alert |
| 08/06/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -54.13% | Geoff Meacham63% | $290 → $305 | Maintains | Underweight | Get Alert |
| 08/01/2018 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | 23.06% | Geoff Meacham63% | $100 → $135 | Maintains | Overweight | Get Alert |
| 07/25/2018 | BIIB | Buy Now | Biogen | $143.09 | 123.64% | Geoff Meacham63% | $295 → $320 | Maintains | Equal-Weight | Get Alert |
| 06/20/2018 | SGMO | Buy Now | Sangamo Therapeutics | $0.85 | 2723.2% | Geoff Meacham63% | → $24 | Initiates | → Buy | Get Alert |
| 06/20/2018 | PTCT | Buy Now | PTC Therapeutics | $56.00 | — | Geoff Meacham63% | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/21/2018 | PRTA | Buy Now | Prothena Corp | $12.93 | — | Geoff Meacham63% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 05/11/2018 | ZYME | Buy Now | Zymeworks | $12.34 | — | Geoff Meacham63% | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/03/2018 | UTHR | Buy Now | United Therapeutics | $314.12 | -69.76% | Geoff Meacham63% | $105 → $95 | Maintains | Underweight | Get Alert |
| 05/03/2018 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 1233.33% | Geoff Meacham63% | $16 → $20 | Maintains | Equal-Weight | Get Alert |
| 05/02/2018 | GILD | Buy Now | Gilead Sciences | $106.96 | -15.85% | Geoff Meacham63% | $95 → $90 | Maintains | Overweight | Get Alert |
| 04/27/2018 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | -8.33% | Geoff Meacham63% | $65 → $55 | Maintains | Equal-Weight | Get Alert |
| 04/05/2018 | PRTA | Buy Now | Prothena Corp | $12.93 | 286.7% | Geoff Meacham63% | $70 → $50 | Maintains | Overweight | Get Alert |
| 04/05/2018 | INCY | Buy Now | Incyte | $60.00 | 125% | Geoff Meacham63% | $165 → $135 | Maintains | Overweight | Get Alert |
| 04/05/2018 | AMGN | Buy Now | Amgen | $319.93 | -43.74% | Geoff Meacham63% | $190 → $180 | Maintains | Equal-Weight | Get Alert |
| 04/05/2018 | ABBV | Buy Now | AbbVie | $214.59 | -52.47% | Geoff Meacham63% | $120 → $102 | Maintains | Equal-Weight | Get Alert |
| 04/05/2018 | BIIB | Buy Now | Biogen | $143.09 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/05/2018 | MYOV | Buy Now | Myovant Sciences | — | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/05/2018 | MRK | Buy Now | Merck & Co | $94.90 | — | Geoff Meacham63% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/05/2018 | PFE | Buy Now | Pfizer | $26.30 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/05/2018 | BHVN | Buy Now | Biohaven | $28.51 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/04/2018 | PTCT | Buy Now | PTC Therapeutics | $56.00 | — | Geoff Meacham63% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 04/02/2018 | BTAI | Buy Now | BioXcel Therapeutics | $2.35 | 538.3% | Geoff Meacham63% | → $240 | Initiates | → Overweight | Get Alert |
| 03/07/2018 | PTCT | Buy Now | PTC Therapeutics | $56.00 | -57.14% | Geoff Meacham63% | $18 → $24 | Maintains | Equal-Weight | Get Alert |
| 03/06/2018 | GILD | Buy Now | Gilead Sciences | $106.96 | -11.18% | Geoff Meacham63% | $90 → $95 | Maintains | Overweight | Get Alert |
| 02/28/2018 | XLRN | Buy Now | Acceleron Pharma | — | — | Geoff Meacham63% | $50 → $54 | Maintains | Overweight | Get Alert |
| 02/22/2018 | UTHR | Buy Now | United Therapeutics | $314.12 | -66.57% | Geoff Meacham63% | $115 → $105 | Maintains | Underweight | Get Alert |
| 02/13/2018 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/01/2018 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | -60.96% | Geoff Meacham63% | $180 → $200 | Maintains | Overweight | Get Alert |
| 01/31/2018 | PFE | Buy Now | Pfizer | $26.30 | 55.89% | Geoff Meacham63% | $38 → $41 | Maintains | Overweight | Get Alert |
| 11/08/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -35.33% | Geoff Meacham63% | $127 → $158 | Maintains | Overweight | Get Alert |
| 11/02/2017 | NBIX | Buy Now | Neurocrine Biosciences | $109.70 | -22.52% | Geoff Meacham63% | $75 → $85 | Maintains | Overweight | Get Alert |
| 10/30/2017 | MRK | Buy Now | Merck & Co | $94.90 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 10/27/2017 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | $135 → $105 | Maintains | Equal-Weight | Get Alert |
| 10/23/2017 | DBVT | Buy Now | DBV Technologies | $5.01 | 498.8% | Geoff Meacham63% | $580 → $300 | Maintains | Overweight | Get Alert |
| 10/20/2017 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | $140 → $135 | Maintains | Equal-Weight | Get Alert |
| 10/20/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | — | Geoff Meacham63% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/20/2017 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/18/2017 | JNJ | Buy Now | Johnson & Johnson | $164.25 | -9.89% | Geoff Meacham63% | $140 → $148 | Maintains | Equal-Weight | Get Alert |
| 10/16/2017 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $55 → $60 | Maintains | Equal-Weight | Get Alert |
| 10/13/2017 | LLY | Buy Now | Eli Lilly | $821.00 | -88.06% | Geoff Meacham63% | $90 → $98 | Maintains | Overweight | Get Alert |
| 10/13/2017 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | $135 → $140 | Maintains | Equal-Weight | Get Alert |
| 10/13/2017 | BMY | Buy Now | Bristol-Myers Squibb | $60.00 | 8.33% | Geoff Meacham63% | $58 → $65 | Maintains | Equal-Weight | Get Alert |
| 10/13/2017 | AMGN | Buy Now | Amgen | $319.93 | -40.61% | Geoff Meacham63% | $180 → $190 | Maintains | Equal-Weight | Get Alert |
| 10/13/2017 | ABBV | Buy Now | AbbVie | $214.59 | -58.06% | Geoff Meacham63% | $68 → $90 | Maintains | Equal-Weight | Get Alert |
| 10/11/2017 | GILD | Buy Now | Gilead Sciences | $106.96 | -15.85% | Geoff Meacham63% | → $90 | Reinstates | Overweight → Overweight | Get Alert |
| 09/29/2017 | PTCT | Buy Now | PTC Therapeutics | $56.00 | -73.21% | Geoff Meacham63% | $22 → $15 | Maintains | Equal-Weight | Get Alert |
| 09/22/2017 | VSAR | Buy Now | Versartis | — | — | Geoff Meacham63% | — | Downgrade | Overweight → Underweight | Get Alert |
| 09/21/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -48.01% | Geoff Meacham63% | $105 → $127 | Maintains | Overweight | Get Alert |
| 09/20/2017 | XLRN | Buy Now | Acceleron Pharma | — | — | Geoff Meacham63% | $42 → $50 | Maintains | Overweight | Get Alert |
| 09/07/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -57.02% | Geoff Meacham63% | $80 → $105 | Assumes | Equal-Weight → Overweight | Get Alert |
| 09/07/2017 | ZYME | Buy Now | Zymeworks | $12.34 | -35.17% | Geoff Meacham63% | → $8 | Assumes | Overweight → Underweight | Get Alert |
| 08/10/2017 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -71.35% | Geoff Meacham63% | $50 → $70 | Maintains | Equal-Weight | Get Alert |
| 08/02/2017 | INCY | Buy Now | Incyte | $60.00 | 175% | Geoff Meacham63% | $180 → $165 | Maintains | Overweight | Get Alert |
| 07/19/2017 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | — | Geoff Meacham63% | — | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/30/2017 | BHVN | Buy Now | Biohaven | $28.51 | 5.23% | Geoff Meacham63% | → $30 | Initiates | → Overweight | Get Alert |
| 03/09/2017 | VSAR | Buy Now | Versartis | — | — | Geoff Meacham63% | → $168 | Initiates | → Overweight | Get Alert |
| 03/03/2017 | PTCT | Buy Now | PTC Therapeutics | $56.00 | -76.79% | Geoff Meacham63% | $20 → $13 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/29/2016 | UTHR | Buy Now | United Therapeutics | $314.12 | — | Geoff Meacham63% | — | Downgrade | Equal-Weight → Underweight | Get Alert |
| 11/29/2016 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.23 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/29/2016 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/29/2016 | JNJ | Buy Now | Johnson & Johnson | $164.25 | — | Geoff Meacham63% | — | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/21/2016 | MYOV | Buy Now | Myovant Sciences | — | — | Geoff Meacham63% | → $18 | Initiates | → Overweight | Get Alert |
| 10/06/2016 | ALNY | Buy Now | Alnylam Pharmaceuticals | $244.30 | -79.53% | Geoff Meacham63% | $85 → $50 | Downgrade | Overweight → Equal-weight | Get Alert |
| 08/10/2016 | INCY | Buy Now | Incyte | $60.00 | 66.67% | Geoff Meacham63% | $85 → $100 | Maintains | Overweight | Get Alert |
| 08/05/2016 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 700% | Geoff Meacham63% | $11 → $12 | Maintains | Equal-Weight | Get Alert |
| 08/04/2016 | PRTA | Buy Now | Prothena Corp | $12.93 | 441.38% | Geoff Meacham63% | $60 → $70 | Maintains | Overweight | Get Alert |
| 07/27/2016 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $48 → $53 | Maintains | Overweight | Get Alert |
| 05/13/2016 | PRTA | Buy Now | Prothena Corp | $12.93 | 364.04% | Geoff Meacham63% | → $60 | Initiates | → Overweight | Get Alert |
| 02/26/2016 | UTHR | Buy Now | United Therapeutics | $314.12 | -53.84% | Geoff Meacham63% | $155 → $145 | Maintains | Equal-Weight | Get Alert |
| 02/19/2016 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 633.33% | Geoff Meacham63% | $15 → $11 | Maintains | Equal-Weight | Get Alert |
| 02/12/2016 | INCY | Buy Now | Incyte | $60.00 | 41.67% | Geoff Meacham63% | $125 → $85 | Maintains | Overweight | Get Alert |
| 02/10/2016 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | $51 → $50 | Maintains | Overweight | Get Alert |
| 02/04/2016 | SGEN | Buy Now | Seagen | — | — | Geoff Meacham63% | → $51 | Initiates | → Overweight | Get Alert |
| 12/03/2015 | DBVT | Buy Now | DBV Technologies | $5.01 | 1057.68% | Geoff Meacham63% | → $580 | Initiates | → Overweight | Get Alert |
| 08/13/2015 | INCY | Buy Now | Incyte | $60.00 | 108.33% | Geoff Meacham63% | → $125 | Initiates | → Overweight | Get Alert |
| 03/04/2015 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 1100% | Geoff Meacham63% | → $18 | Initiates | → Equal-Weight | Get Alert |
| 01/06/2015 | UTHR | Buy Now | United Therapeutics | $314.12 | -57.02% | Geoff Meacham63% | → $135 | Initiates | → Equal-weight | Get Alert |
| 01/06/2015 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | → $120 | Initiates | → Equal-weight | Get Alert |
| 11/21/2014 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -30.52% | Geoff Meacham63% | $418 → $462 | Maintains | Buy | Get Alert |
| 02/12/2014 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -41.8% | Geoff Meacham63% | → $387 | Reinstates | → Buy | Get Alert |
| 12/26/2013 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Geoff Meacham63% | $129 → $162 | Maintains | Buy | Get Alert |
| 10/01/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -48.12% | Geoff Meacham63% | $310 → $345 | Maintains | Buy | Get Alert |
| 09/20/2013 | INCY | Buy Now | Incyte | $60.00 | -40% | Geoff Meacham63% | $22 → $36 | Maintains | Equal-Weight | Get Alert |
| 04/12/2013 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -66.92% | Geoff Meacham63% | $200 → $220 | Maintains | Buy | Get Alert |
| 02/15/2013 | INCY | Buy Now | Incyte | $60.00 | -65% | Geoff Meacham63% | $19 → $21 | Maintains | Equal-Weight | Get Alert |
| 02/15/2013 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Geoff Meacham63% | $120 → $124 | Maintains | Buy | Get Alert |
| 10/10/2012 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Geoff Meacham63% | $118 → $130 | Maintains | Buy | Get Alert |
| 10/05/2012 | CELG | Buy Now | Celgene | — | — | Geoff Meacham63% | $37.5 → $43.5 | Maintains | Overweight | Get Alert |
| 09/24/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -74.13% | Geoff Meacham63% | $168 → $172 | Maintains | Buy | Get Alert |
| 08/28/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -74.74% | Geoff Meacham63% | $164 → $168 | Maintains | Buy | Get Alert |
| 08/28/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -74.74% | Geoff Meacham63% | $164 → $168 | Maintains | Buy | Get Alert |
| 08/03/2012 | INCY | Buy Now | Incyte | $60.00 | -65% | Geoff Meacham63% | $24 → $21 | Maintains | Equal-Weight | Get Alert |
| 05/29/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -76.24% | Geoff Meacham63% | $154 → $158 | Maintains | Buy | Get Alert |
| 05/08/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -76.84% | Geoff Meacham63% | $150 → $154 | Maintains | Buy | Get Alert |
| 04/23/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -78.04% | Geoff Meacham63% | $135 → $146 | Maintains | Buy | Get Alert |
| 03/27/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -79.7% | Geoff Meacham63% | $130 → $135 | Maintains | Buy | Get Alert |
| 03/26/2012 | ALXN | Buy Now | Alexion Pharmaceuticals | — | — | Geoff Meacham63% | $92 → $99 | Maintains | Buy | Get Alert |
| 02/14/2012 | REGN | Buy Now | Regeneron Pharmaceuticals | $664.96 | -80.45% | Geoff Meacham63% | $105 → $130 | Maintains | Buy | Get Alert |
